Updated guidelines for the management of Parkinson's disease

被引：17

作者：

Bhatia, K

Brooks, DJ ^{[1
]}

Burn, DJ

Clarke, CE

Grosset, DG

MacMahon, DG

Playfer, J

Schapira, AHV

Stewart, D

Widliams, AC

机构：

[1] Hammersmith Hosp, Imperial Coll Sch Med, London W12 0NN, England

[2] Univ London, Dept Clin Neurol, Inst Neurol, London, England

[3] Newcastle Gen Hosp, Dept Neurol, Reg Neurosci Ctr, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England

[4] City Hosp NHS Trust, Dept Neurol, Birmingham, W Midlands, England

[5] Univ Birmingham, Birmingham, W Midlands, England

[6] So Gen Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland

[7] Univ Plymouth, Plymouth PL4 8AA, Devon, England

[8] Royal Liverpool Univ Hosp, Liverpool, Merseyside, England

[9] UCL, Dept Clin Neurosci, Royal Free & Univ Coll Med Sch, London, England

[10] Victoria Infirm, Glasgow G42 9TY, Lanark, Scotland

[11] Queen Elizabeth Hosp, Dept Neurosci, Birmingham B15 2TH, W Midlands, England

来源：

HOSPITAL MEDICINE | 2001年 / 62卷 / 08期

关键词：

D O I：

10.12968/hosp.2001.62.8.1621

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

New data on diagnosis, drug therapy, surgery and psychosocial concerns have emerged since the publication of the 1998 Guidelines for the Management of Parkinson's Disease. This article reviews new data and addresses issues left unanswered in the previous guidelines.

引用

页码：456 / 470

页数：15

共 126 条

[1]

Agid Y, 1999, MOVEMENT DISORD, V14, P38

[2]

ALBANESE A, 1999, SCHWEIZ ARCH NEUROL, V150, P288

[3] Depression in Parkinson's disease - Must be properly diagnosis and treated to avoid serious morbidity [J].

Allain, H ;

Schuck, S ;

Mauduit, N .

BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1287-1288

[4]

[Anonymous], 1996, Ann Neurol, V39, P37

[5]

[Anonymous], 1997, Ann Neurol, V42, P747

[6]

Baron MS, 2000, MOVEMENT DISORD, V15, P230, DOI 10.1002/1531-8257(200003)15:2<230::AID-MDS1005>3.0.CO

[7]

2-U

[8]

BEDARD PJ, 1997, DOPAMINE AGONISTS EA, P101

[9]

BEEKMAN ATF, 1999, MENTAL DYSFUNCTION 2, V11, P263

[10] Investigation by Parkinson's disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early mild Parkinson's disease: further results of randomised trial and confidential inquiry [J].

Ben-Shlomo, Y ;

Churchyard, A ;

Head, J ;

Hurwitz, B ;

Overstall, P ;

Ockelford, J ;

Lees, AJ .

BRITISH MEDICAL JOURNAL, 1998, 316 (7139) :1191-1196

← 1 2 3 4 5 6 7 8 9 10 →